Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups


Siqi Li

MS.c BSc

DPhil student

  • Peer Supporter of the Medical Science Division
  • MCR Alumni representative of Kellogg college


Siqi currently is collaborating with the nucleic acid group to study strategies on enhancing nucleic acid therapeutics in cancer. She mainly focuses on utilizing cell-penetrating peptides to deliver small interfering RNA and CRISPR/Cas9. 


Siqi Li joined Professor Vallis's group, Department of Oncology as a DPhil student in 2020. She is also a collaborative student in the Department of Chemistry. Prior to studying at Oxford, she had her master's degree in molecular medicine at Imperial College London where she contributed to the development of aptamer-based diagnostic tools for type 2 diabetes under the supervision of Professor Tony Cass and Professor Guy Rutter.